ImmunoMind (https://immunomind.io) provides a biomarker discovery platform for immune-based diagnostics and treatment solutions for viral infections. The platform can accelerate vaccine development and discovery of broadly-neutralizing antibodies.

ImmunoMind can deliver clinical insights from single-cell and immunosequencing data of COVID patients.
The platform is based on the latest breakthroughs in immunology and Deep Neural Networks.

ImmunoMind is trusted by the global community.
Our software tools helped Stanford, UCSF, MIT, King's College London and more than 24,000 users worldwide gain clinical insights from immune cell data.